Brokerages expect AFLAC Incorporated (NYSE:AFL) to announce $5.46 billion in sales for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for AFLAC’s earnings, with the lowest sales estimate coming in at $5.35 billion and the highest estimate coming in at $5.53 billion. AFLAC reported sales of $5.59 billion in the same quarter last year, which indicates a negative year over year growth rate of 2.3%. The company is scheduled to announce its next quarterly earnings results on Thursday, July 25th.
According to Zacks, analysts expect that AFLAC will report full-year sales of $21.79 billion for the current fiscal year, with estimates ranging from $21.41 billion to $22.23 billion. For the next financial year, analysts anticipate that the company will post sales of $21.83 billion, with estimates ranging from $21.40 billion to $22.52 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow AFLAC.
AFLAC (NYSE:AFL) last posted its quarterly earnings data on Thursday, April 25th. The financial services provider reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.07. The company had revenue of $5.66 billion during the quarter, compared to analysts’ expectations of $5.46 billion. AFLAC had a net margin of 13.42% and a return on equity of 13.62%. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.05 EPS.
NYSE:AFL opened at $49.53 on Friday. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.06 and a quick ratio of 0.06. The stock has a market capitalization of $36.61 billion, a price-to-earnings ratio of 11.91, a PEG ratio of 3.38 and a beta of 0.79. AFLAC has a 1-year low of $41.45 and a 1-year high of $50.66.
The business also recently announced a quarterly dividend, which will be paid on Monday, June 3rd. Stockholders of record on Wednesday, May 22nd will be paid a $0.27 dividend. The ex-dividend date of this dividend is Tuesday, May 21st. This represents a $1.08 dividend on an annualized basis and a dividend yield of 2.18%. AFLAC’s dividend payout ratio (DPR) is presently 25.96%.
In other news, insider Teresa L. White sold 12,338 shares of the company’s stock in a transaction dated Wednesday, February 13th. The shares were sold at an average price of $49.06, for a total value of $605,302.28. Following the sale, the insider now owns 56,343 shares in the company, valued at approximately $2,764,187.58. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Masatoshi Koide sold 27,120 shares of the company’s stock in a transaction dated Monday, February 4th. The shares were sold at an average price of $47.71, for a total transaction of $1,293,895.20. Following the completion of the sale, the insider now owns 52,858 shares in the company, valued at approximately $2,521,855.18. The disclosure for this sale can be found here. In the last 90 days, insiders sold 89,244 shares of company stock worth $4,363,557. Company insiders own 1.30% of the company’s stock.
Institutional investors have recently modified their holdings of the company. Cordasco Financial Network acquired a new stake in AFLAC during the first quarter worth about $25,000. Financial Advantage Inc. acquired a new stake in AFLAC during the fourth quarter worth about $29,000. Baystate Wealth Management LLC raised its stake in AFLAC by 203.5% during the first quarter. Baystate Wealth Management LLC now owns 601 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 403 shares during the period. Nelson Roberts Investment Advisors LLC acquired a new stake in AFLAC during the fourth quarter worth about $33,000. Finally, IMS Capital Management acquired a new stake in AFLAC during the third quarter worth about $35,000. Institutional investors and hedge funds own 68.43% of the company’s stock.
Aflac Incorporated, through its subsidiaries, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.
Recommended Story: How Important is Technical Analysis of Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AFLAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AFLAC and related companies with MarketBeat.com's FREE daily email newsletter.